Journal of Neurochemistry · 2005 · 91 citations · 73 references
MedicineNeurosciencePsychiatryMolecular NeurobiologyMolecular NeuroscienceNeuropharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyDopaminergic PharmacologySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersAntipsychotic ActionBeta-catenin RegulationClozapine PharmacologyDopamine D2-like ReceptorsGlycogen Synthase Kinase 3 RegulationGlycogen Synthase Kinase 3 SignalingGlycogen Synthase Kinase RegulationSchizophrenia Genetics
Protein kinase B and glycogen synthase kinase-3 have been identified as susceptibility genes for schizophrenia and altered protein and mRNA levels have been detected in the brains of schizophrenics post-mortem. Recently, we reported that haloperidol, clozapine and risperidone alter glycogen synthase kinase-3 and beta-catenin protein expression and glycogen synthase kinase-3 phosphorylation levels in the rat prefrontal cortex and striatum. In the current study, beta-catenin, adenomatous polyposis coli, Wnt1, dishevelled and glycogen synthase kinase-3 were examined in the ventral midbrain and hippocampus using western blotting. In addition, beta-catenin and GSK-3 were examined in the substantia nigra and ventral tegmental area using confocal and fluorescence microscopy. The results indicate that repeated antipsychotic administration results in significant elevations in glycogen synthase kinase-3, beta-catenin and dishevelled-3 protein levels in the ventral midbrain and hippocampus. Raclopride causes similar changes in beta-catenin and GSK-3 in the ventral midbrain, suggesting that D2 dopamine receptor antagonism mediated the changes observed following antipsychotic administration. In contrast, amphetamine, a drug capable of inducing psychotic episodes, had the opposite effect on beta-catenin and GSK-3 in the ventral midbrain. Collectively, the results suggest that antipsychotics may exert their beneficial effects through modifications to proteins that are associated with the canonical Wnt pathway.
73
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Darren A.E. Cross, Dario R. Alessi, Philip Cohen et al. · Nature · 1995 · 5.2K citations
Functional interaction of β-catenin with the transcription factor LEF-1
Jürgen Behrens, Jens Peter von Kries, Michael Kühl et al. · Nature · 1996 · 2.9K citations
β‐catenin is a target for the ubiquitin–proteasome pathway
Hermann Aberle, Andreas Bauer, Jörg Stappert et al. · The EMBO Journal · 1997 · 2.5K citations
Antipsychotic drug doses and neuroleptic/dopamine receptors
Philip Seeman, T. Lee, M. Chau-Wong et al. · Nature · 1976 · 1.6K citations
Medicine, Pharmacology, Psychiatry +13
A new member of the frizzled family from Drosophila functions as a Wingless receptor
Purnima Bhanot, Marcel R.M. van den Brink, Cindy Harryman Samos et al. · Nature · 1996 · 1.5K citations
Life Sciences, Biology, Genetics +8